Publication Cover
Materials Technology
Advanced Performance Materials
Volume 36, 2021 - Issue 6
217
Views
6
CrossRef citations to date
0
Altmetric
Research Article

The synthesis and characterisation of curcumin loaded Ag (1-X) Ni X Fe2 O4 for drug delivery

, &
Pages 339-346 | Received 27 Feb 2020, Accepted 10 Apr 2020, Published online: 30 Apr 2020
 

ABSTRACT

A simple procedure of solvothermal synthesis of Silver doped Nickel ferrite nanoparticle is described in this paper for the application of drug delivery. The microwave absorption and SERS phenomena of silver nanoparticles and water-absorbent property of the polymer material such as polyethylene glycol (PEG) to bypass fast identification by the antibodies are made use in the synthesis of Ag-doped nickel ferrite with PEG as a solvent. The ferrite sample was distinguished using XRD, FTIR, SEM, TEM, and VSM. The absorption wavelength and corresponding band gap energy were calculated by UV-Vis spectroscopy. The drug delivery efficiency of silver doped nickel ferrite sample was conducted with curcumin by changing pH, initial drug concentration and specified magnetic field. Results prove that the addition of silver and polyethylene glycol in nickel ferrites changes the properties of the nanoparticle and recognised as a good material for drug delivery applications.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.